Cargando…

SUSD2 expression correlates with decreased metastasis and increased survival in a high-grade serous ovarian cancer xenograft murine model

The cause of death among high-grade serous ovarian cancer (HGSOC) patients involves passive dissemination of cancer cells within the peritoneal cavity and subsequent implantation of cancer spheroids into adjacent organs. Sushi Domain Containing 2 (SUSD2) encodes a type I transmembrane protein contai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheets, Jordan N., Patrick, Mitch E., Egland, Kristi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299533/ https://www.ncbi.nlm.nih.gov/pubmed/32595828 http://dx.doi.org/10.18632/oncotarget.27626

Ejemplares similares

SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance
por: Sheets, J N, et al.
Publicado: (2016)

SUSD2 Proteolytic Cleavage Requires the GDPH Sequence and Inter-Fragment Disulfide Bonds for Surface Presentation of Galectin-1 on Breast Cancer Cells
por: Patrick, Mitch E., et al.
Publicado: (2019)

SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer
por: Hultgren, Elizabeth M., et al.
Publicado: (2017)

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
por: Dong, Ruifen, et al.
Publicado: (2016)

Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma
por: De Thaye, Elien, et al.
Publicado: (2020)

In Vitro Implantation Model Using Human Endometrial SUSD2(+)
por: Rahimipour, Marzieh, et al.
Publicado: (2021)

Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma
por: Serna-Gallegos, Tasha, et al.
Publicado: (2016)

Low-Grade Ovarian Serous Adenocarcinoma with Lymph Node Metastasis in Neck
por: Chen, Shih-Lung, et al.
Publicado: (2021)

Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2020)

Skin Metastasis of Low-Grade Ovarian Serous Carcinoma: A Case Report
por: Ching, Lauren M, et al.
Publicado: (2023)

Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
por: Shen, Yen Ting, et al.
Publicado: (2019)

CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
por: Kleinmanns, Katrin, et al.
Publicado: (2020)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
por: Criscuolo, Daniela, et al.
Publicado: (2022)

Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice
por: De Haven Brandon, Alexis, et al.
Publicado: (2020)

Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research
por: Cybula, Magdalena, et al.
Publicado: (2021)

IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer
por: Dongol, Samina, et al.
Publicado: (2020)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Gastric metastasis of ovarian serous cystadenocarcinoma
por: Yang, Shiqiang
Publicado: (2018)

Survival of Advanced Stage High-Grade Serous Ovarian Cancer Patients in the Republic of Macedonia
por: Aluloski, Igor, et al.
Publicado: (2017)

Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival
por: Carlson, Joseph W., et al.
Publicado: (2018)

Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
por: Bischof, Katharina, et al.
Publicado: (2019)

Protein anabolism is key to long-term survival in high-grade serous ovarian cancer
por: Wang, Lingxiang, et al.
Publicado: (2020)

The Complement Regulator Susd4 Influences Nervous-System Function and Neuronal Morphology in Mice
por: Zhu, Hongling, et al.
Publicado: (2020)

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology
por: Chen, Ming, et al.
Publicado: (2014)

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
por: Harrington, Brittney S, et al.
Publicado: (2016)

The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models
por: Ho, Gwo Yaw, et al.
Publicado: (2023)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
por: Hollis, Robert L., et al.
Publicado: (2022)

Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2021)

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
por: Kim, Se Ik, et al.
Publicado: (2022)

Stage, treatment and survival of low‐grade serous ovarian carcinoma in the Netherlands: A nationwide study
por: De Decker, Koen, et al.
Publicado: (2023)

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes
por: Robertson, Sharon E., et al.
Publicado: (2023)

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
por: Evans, Rick L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u8qarc8s3eab8hfb7nrfra86j1